Log In
BCIQ
Print this Print this
 

Seriveo (PSX2005)

  Manage Alerts
Collapse Summary General Information
Company Circassia Pharmaceuticals plc
DescriptionCombination of particle-engineered versions of fluticasone and salmeterol in a pressurized metered dose inhaler (pMDI)
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$152.7M

$106.9M

$45.8M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/15/2015

$152.7M

$106.9M

$45.8M

Get a free BioCentury trial today